11 – 20 of 48
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The serotonergic system in L-DOPA-induced dyskinesia : pre-clinical evidence and clinical perspective
(
- Contribution to journal › Article
-
Mark
Animal models of l-DOPA-induced dyskinesia : the 6-OHDA-lesioned rat and mouse
(
- Contribution to journal › Article
-
Mark
Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT1A receptor biased agonists
(
- Contribution to journal › Article
- 2017
-
Mark
CK2 oppositely modulates L-DOPA-induced dyskinesia via striatal projection neurons expressing D1 or D2 receptors
(
- Contribution to journal › Article
-
Mark
BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats
(
- Contribution to journal › Article
-
Mark
Infusional Therapies, Continuous Dopaminergic Stimulation, and Nonmotor Symptoms
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
The Role of the Cortico-Basal Ganglia-System in Voluntary Movements
(
- Thesis › Doctoral thesis (compilation)
- 2015
-
Mark
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
(
- Contribution to journal › Article
- 2013
-
Mark
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
(
- Contribution to journal › Article
-
Mark
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article